AUAUniversity26 Mars 2021

Metastatic Hormone Sensitive Prostate Cancer - Expert Guidance For Urologists

This educational series is supported by independent educational grants from: Astellas, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC and Pfizer, Inc. CME Available: https://auau.auanet.org/node/30861 In 2020, the Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline was released and will provide critical guidance as the management of advanced prostate cancer patients continues to expand. To increase urologists understanding of how to translate the latest scientific advances and the Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline into their clinical practice, the featured 60-minute panel discussion includes a thorough discussion of new trials and approval of agents directed at the androgen axis for treatment of mHSPC. Faculty will highlight the management of patients with advanced prostate cancer and how therapeutic options have been incorporated into evidence-based guidelines. Learning Objectives: At the conclusion of the activity, participants will be able to: 1. Identify the active agents and their mechanism of action in the management of metastatic hormone sensitive prostate cancer (mHSPC). 2. Review the evidence and outcomes on the treatment of mHSPC as outlined in the newly released Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline. 3. Improve diagnostic and therapeutic decision making processes by illustrating the application of these guidelines in urological practice. 4. Analyze breakthrough treatments in the management of advanced and mHSPC. 5. Describe the indications and combinations for treatment with approved agents in the management of mHSPC.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(448)

AUA2026: Focus on: ADT in the Modern Era

AUA2026: Focus on: ADT in the Modern Era - Balancing Cancer Control and Cardiovascular Safety CME Available: https://cme.auanet.org/URL/FOCUS265ONL LEARNING OBJECTIVES: After participating in this C...

15 Juli 1h 9min

Innovations in the Surgical Management of BPH (2026)

Innovations in the Surgical Management of BPH (2026) CME Available: https://cme.auanet.org/URL/surgical-treatment-bph-2026 LEARNING OBJECTIVES: After participating in this educational series, parti...

8 Juli 36min

Update Series (2026) Lesson 18: Testosterone Therapy: Is It Safe? A Case-Based Approach

Update Series (2026) Lesson 18: Testosterone Therapy: Is It Safe? A Case-Based Approach Now in its 45th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicin...

1 Juli 35min

AUA Guidelines: Advanced Prostate Cancer

AUA Guidelines: Advanced Prostate Cancer Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Kristen R. Scarpato, MD, MPH To access the full guideline, please use the following link: https://www.auanet.org/...

24 Juni 22min

AUA2026: Focus on: Metastatic Urothelial Carcinoma (mUC)

AUA2026: Focus on: Metastatic Urothelial Carcinoma CME Available: https://cme.auanet.org/URL/FOCUS264ONL LEARNING OBJECTIVES: After participating in this CME activity, participants will be able to: ...

17 Juni 1h 7min

AUA Guidelines: Clinically Localized Prostate Cancer

AUA Guidelines: Clinically Localized Prostate Cancer Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: James Eastham, MD, FACS To access the full guideline, please use the following link: https://www.auan...

10 Juni 28min

Update Series (2026): Kidney Stones and the Infected Patient

Update Series (2026): Kidney Stones and the Infected Patient Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Mantu Gupta, MD Now in its 45th installment, the AUA Update Series is renowned for delivering...

3 Juni 21min

AUA2026: Focus on: Biomarkers, MRI and PSMA PET Imaging in Prostate Cancer Webcast

AUA2026: Focus on: Biomarkers, MRI and PSMA PET Imaging in Prostate Cancer Webcast CME Available: https://cme.auanet.org/URL/FOCUS262ONL LEARNING OBJECTIVES: After participating in this CME activity...

27 Maj 1h 15min